CIA
CRL icon

CSat Investment Advisory’s Charles River Laboratories CRL Stock Holding History

CSat Investment Advisory’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-190
Closed -$43K – 620
2020
Q3 		$43K Buy
190
+25
+15% +$5.19K ﹤0.01% 685
2020
Q2 		$29K Buy
165
+8
+5% +$1.28K ﹤0.01% 751
2020
Q1 		$20K Buy
157
+27
+21% +$4.05K ﹤0.01% 722
2019
Q4 		$20K Buy
130
+16
+14% +$2.21K 0.01% 782
2019
Q3 		$15K Buy
114
+16
+16% +$2.15K ﹤0.01% 789
2019
Q2 		$14K Buy
+98
New +$13.3K ﹤0.01% 772

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

CSat Investment Advisory's CRL Position: Q4 2020 in Review

CSat Investment Advisory sold out of Charles River Laboratories (CRL) in Q4 2020, closing a stake of 190 shares — an estimated $43K sold.

CSat Investment Advisory first reported a position in CRL in Q2 2019 and held it in 6 quarters. The position peaked at $43K in Q3 2020. 538 funds tracked by Wall St. Rank hold CRL as of Q4 2020.

  • CSat Investment Advisory reported no remaining Charles River Laboratories position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 190 Charles River Laboratories shares in Q4 2020, an estimated $43K.
  • CSat Investment Advisory first reported a position in Charles River Laboratories in Q2 2019 and held it in 6 quarters.
  • CSat Investment Advisory's Charles River Laboratories position peaked at $43K in Q3 2020.
  • 538 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.